Power and Sample Size in Cost- Effectiveness Analysis
Eugene M. Laska,
Morris Meisner and
Carole Siegel
Medical Decision Making, 1999, vol. 19, issue 3, 339-343
Abstract:
For resource allocation under a constrained budget, optimal decision rules for mutually exclusive programs require that the treatment with the highest incremental cost-effec tiveness ratio (ICER) below a willingness-to-pay (WTP) criterion be funded. This is equivalent to determining the treatment with the smallest net health cost. The designer of a cost-effectiveness study needs to select a sample size so that the power to reject the null hypothesis, the equality of the net health costs of two treatments, is high. A recently published formula derived under normal distribution theory overstates sample- size requirements. Using net health costs, the authors present simple methods for power analysis based on conventional normal and on nonparametric statistical theory. Key words: cost-effectiveness analysis; power; sample size; cost-effectiveness ratios; net health costs; net health benefits; statistical analysis. (Med Decis Making 1999;19: 339-343)
Date: 1999
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (4)
Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X9901900312 (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:19:y:1999:i:3:p:339-343
DOI: 10.1177/0272989X9901900312
Access Statistics for this article
More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().